Previous 10 | Next 10 |
This article highlights the worst performing foreign stocks year to date 2019 through data as of May 21. The YCharts equity screening tool database counts 2,384 foreign stocks that either trades as an American Depository Receipt "ADRs," is primarily listed on a U.S. exchange, or is a foreign...
Health Canada has approved Mylan's (NASDAQ: MYL ) Ogivri (trastuzumab), a biosimilar to Herceptin (trastuzumab) co-developed with Biocon ( OTC:BCNQY ), for the treatment of HER2-overexpressing breast cancer and metastatic stomach cancer. More news on: Mylan N.V., Biocon Ltd. ADR, He...
DUBLIN and HERTFORDSHIRE, England and PITTSBURGH , May 20, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today announced the presentation of data from its pivotal Phase 3 efficacy studies and a 52-...
HERTFORDSHIRE, England , and PITTSBURGH , May 18, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced four scientific abstracts from the Wixela™ Inhub™ (fluticasone propionate and salmeterol inhalation powder, USP) development ...
Endpoints News reports that Gilead Sciences ( GILD +1.6% ) CEO Daniel O'Day spent more than three hours yesterday trying to justify the $2,000/month price of Truvada (emtricitabine and tenofovir disoproxil fumarate) before a U.S. House committee on oversight and reform. The FDA approved ...
HERTFORDSHIRE, England and PITTSBURGH , May 17, 2019 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) yesterday presented at the Bank of America Merrill Lynch Healthcare Conference, where the company announced that it will host an Investor Day on July 31, 2019 in New York ...
Mylan corporate logo. Source: Bloomberg Mylan's (MYL) revenue and operating income are in rapid decline. Its $14 billion debt load makes the decline even more problematic. Fitch Ratings recently revised Mylan's outlook to negative and implied a downgrade could leave the company's debt wi...
HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India , May 15, 2019 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that final data from the HERITAGE study will be presented at the 2019 American Society of Clinic...
Roche ( RHHBY ) announced that it had received FDA approval for Kadcyla in patients with early-stage breast cancer. This is a good win for both the company and the patients. For the company it helps to boost the possible revenue for Kadcyla. For patients, it gives them a better opportuni...
Source INTRODUCTION In recent years there has been a populist rush to embrace socialism by those in the US who’re politically on the hard left. Although this populist theme has gained traction with some Democrats and certainly with the media, it does not appear to be favored by ...
News, Short Squeeze, Breakout and More Instantly...
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, 2020 HERTFORDSHIRE, England and PITTSBURGH , Nov. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ...
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more. A long-awaited deal will soon be done. Pfizer (NYSE: PFE) and Mylan (NASDAQ: MYL) announced last week that the U.S. Federal Trade Commission has approved the planned merger of Pfizer's...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 HERTFORDSHIRE , England, and PITTSBURGH, Nov. 2, 2020 /PRNews...